Changing the dynamics of organic
cannabinoid-rich industrial hemp cultivation
You are here, exploring, for one of three reasons...
1 - You want to make money from investing.
2 - You think the Hemp business is interesting.
3- You want to support doing great things in the cannabidiol and healthcare market.
or maybe it is all of the above.
No matter why you are here - WELCOME! We hope you will join us on our journey.
They say to never start with a negative but we have to...
To be upfront and transparent, we aren't a group of cool millenials hanging out on a trust fund looking for the next cool thing. Bummer!
What we are is a team of middle aged sales, marketing and agricultural professionals that have identified a great and stable market opportunity in the legal arena of Hemp cultivation for medicinal and medical use. To learn More about our team Click Here.
If you don't know much about Hemp, or think it is the same as cannabis, let us bring you up to speed.
Hemp is one of the oldest domesticated crops known to mankind.
For more than ten thousand years hemp has been utilized to manufacture paper, textiles, make cordage and rope etc. and has been embraced globally as a major agricultural product.
Hemp is also one of the new pathways to combatting a series of issues and effects.
As a group, we have each had family and friends that have suffered the effects of cancer, Alzheimer's, PTSD, and drug addiction. Our view is that the industrial pharmaceutical companies, through the introduction of countless additive drugs, have created an industry focused on expanding profits over curing people.
We believe there must be a better way.
The emerging CBD market is challenging the status quo. Globally and in the U.S., research scientists recognize industrial hemp as a legal substance and source containing cannabidiols.
CBD is rapidly gaining the attention of the medical community as a way of treating the effects of disease states associated with PTSD, glaucoma, epileptic seizures, the progression of Alzheimer's disease, slowing cancer's growth, preventing the side effects from the treatment of hepatitis C, thwarting the pain of multiple sclerosis and a host of other conditions that are most commonly treated with opioids and other pharma medicines.
So, we set out to build a commercial scale industrial hemp farm targeting cannabinoid rich strains that include hemp CBD's to supply the rapidly growing U.S. market. In 2016 the consumer hemp CBD market was $130MM and is expected to reach $736MM by 2020 which is a 54% CAGR. We expect the wholesale market to follow or out perform this growth trend. While the estimated market size varies widely, the DEA's recent removal of CBD from Schedule 1 and the potential further protections under the 2018 farm bill will continue drive the market upwards.
To learn more about the differences between Cannabis and Hemp Click Here.